These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16353962)

  • 21. Formulation for a novel inhaled peptide therapeutic for idiopathic pulmonary fibrosis.
    Hengsawas Surasarang S; Florova G; Komissarov AA; Shetty S; Idell S; Williams RO
    Drug Dev Ind Pharm; 2018 Feb; 44(2):184-198. PubMed ID: 28835128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stabilization of rasburicase and physico-chemical characterization of the resulting injectable formulation.
    Bayol A; Breul T; Dupin P; Menegotto J; Aleman C; Duplaa H; Faure P; Bonnet MC; Bauer M
    Drug Dev Ind Pharm; 2004 Sep; 30(8):877-89. PubMed ID: 15521333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability characterization and appearance of particulates in a lyophilized formulation of a model peptide hormone-human secretin.
    Srinivasan C; Siddiqui A; Korang-Yeboah M; Khan MA
    Int J Pharm; 2015 Mar; 481(1-2):104-13. PubMed ID: 25636302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation on formulation and preparation of adenovirus encoding human endostatin lyophilized powders.
    Chen S; Guo D; Guo B; Liu J; Shen Y; Xu X; Huang W; Guo S
    Int J Pharm; 2012 May; 427(2):145-52. PubMed ID: 22234038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules.
    Desai D; Kothari S; Huang M
    Int J Pharm; 2008 Apr; 354(1-2):77-81. PubMed ID: 18194844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry.
    Huyge K; Van Reeth K; De Beer T; Landman WJ; van Eck JH; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Apr; 80(3):649-56. PubMed ID: 22155763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Freeze-drying of proteins from a sucrose-glycine excipient system: effect of formulation composition on the initial recovery of protein activity.
    Liu W; Wang DQ; Nail SL
    AAPS PharmSciTech; 2005 Sep; 6(2):E150-7. PubMed ID: 16353972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of excipients on the stability and structure of lyophilized recombinant human growth hormone.
    Costantino HR; Carrasquillo KG; Cordero RA; Mumenthaler M; Hsu CC; Griebenow K
    J Pharm Sci; 1998 Nov; 87(11):1412-20. PubMed ID: 9811499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Crystallization Tendency of Commercially Available Amorphous Tacrolimus Formulations Exposed to Different Stress Conditions.
    Trasi NS; Purohit HS; Taylor LS
    Pharm Res; 2017 Oct; 34(10):2142-2155. PubMed ID: 28687987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Freeze-drying of enzymes in case of water-binding and non-water-binding substrates.
    Pisano R; Rasetto V; Barresi AA; Kuntz F; Aoude-Werner D; Rey L
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):974-83. PubMed ID: 23500114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
    Anhorn MG; Mahler HC; Langer K
    Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystallization and X-ray diffraction of spray-dried and freeze-dried amorphous lactose.
    Haque MK; Roos YH
    Carbohydr Res; 2005 Feb; 340(2):293-301. PubMed ID: 15639249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Merits and Limitations of Dynamic Vapor Sorption Studies on the Morphology and Physicochemical State of Freeze-Dried Products.
    Kunz C; Gieseler H
    J Pharm Sci; 2018 Aug; 107(8):2179-2191. PubMed ID: 29698727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of excipients for enhanced thermal stabilization of a human type 5 adenoviral vector through spray drying.
    LeClair DA; Cranston ED; Xing Z; Thompson MR
    Int J Pharm; 2016 Jun; 506(1-2):289-301. PubMed ID: 27130366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystallization and X-ray diffraction of crystals formed in water-plasticized amorphous lactose.
    Jouppila K; Kansikas J; Roos YH
    Biotechnol Prog; 1998; 14(2):347-50. PubMed ID: 9548791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naked plasmid DNA formulation: effect of different disaccharides on stability after lyophilisation.
    Quaak SG; Haanen JB; Beijnen JH; Nuijen B
    AAPS PharmSciTech; 2010 Mar; 11(1):344-50. PubMed ID: 20204715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid determination of dry layer mass transfer resistance for various pharmaceutical formulations during primary drying using product temperature profiles.
    Kuu WY; Hardwick LM; Akers MJ
    Int J Pharm; 2006 Apr; 313(1-2):99-113. PubMed ID: 16513303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.